EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY

Active

Int'l non-profit associationfounded 198838 yrs activeMarnixlaan 17, 1000 Brussel, BelgiumKBO/BCE: BE 0432.894.370

Summary

EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY has been active since 1988 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4.12M and a net result of €235k. Equity is growing by ~10.3% per year across the filed fiscal years. Its solvency ranks better than 47% of 928 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Risk analysis Watch Report Compare

EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGYActiveChecked score 81/100

Risk analysis Report Compare

Checked score

Score 2025

81 / 100

Excellent

Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability72▼-8

Solvency66▼-2

Growth78=

Track record100

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Credit up to €330k at 30 days acceptable

Liquidity ample (current ratio 5.7 against 6.13 in 2024; short-term debt: 17.4% and cash: 27.1% of total assets), but 59% of the assets are financed with debt.

Credit check for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Lower-risk legal form

Companies with this legal form statistically fail less often than a BV.

KBO · legal form

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Long track record

A company with a long track record statistically fails less often than a young one.

KBO · incorporation date

Age against the risk zone

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 82

Relative position

BE, all sectors

reference

Office administrative, office support and other business support activities (NACE 82)

about 37% fewer bankruptcies

← fewer bankruptcies more bankruptcies →

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

41%

Return on assets

2.3%

Age of the figures

9 mo

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-05-2026, 63 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

63 d early

2024

77 d early

2023

75 d early

2022

46 d early

2021

57 d early

2020

75 d early

2019

73 d early

← before the deadline after the deadline →

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

25-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover

Not included in this filing

EBIT margin

Not included in this filing

Net result

€235k▼ 71.6%

2024 · €829k

2018: €87k 2019: €41k▼ -53.6% vs 2018 2020: €-420k▼ -1136% vs 2019lowest in 8 years 2021: €44k▲ +111% vs 2020 2022: €468k▲ +955% vs 2021 2023: €628k▲ +34.1% vs 2022 2024: €829k▲ +31.9% vs 2023highest in 8 years 2025: €235k▼ -71.6% vs 2024

2018 → 2025

Working capital

€8.24M▲ 14.5%

2024 · €7.19M

2018: €5.16M 2019: €5.32M▲ +3.1% vs 2018 2020: €2.82M▼ -47.0% vs 2019lowest in 8 years 2021: €4.13M▲ +46.4% vs 2020 2022: €4.98M▲ +20.6% vs 2021 2023: €5.40M▲ +8.5% vs 2022 2024: €7.19M▲ +33.2% vs 2023 2025: €8.24M▲ +14.5% vs 2024highest in 8 years

2018 → 2025

Trend over the years

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20212022202320242025Trend

Equity€1.96M-€2.43M▲ 23.9%€3.06M▲ 25.8%€3.89M▲ 27.1%€4.12M▲ 6.0% 2021: €1.96Mlowest in 5 years 2022: €2.43M▲ +23.9% vs 2021 2023: €3.06M▲ +25.8% vs 2022 2024: €3.89M▲ +27.1% vs 2023 2025: €4.12M▲ +6.0% vs 2024highest in 5 years

Operating result€83k-€720k▲ 767%€518k▼ 28.1%€886k▲ 71.1%€619k▼ 30.2% 2021: €83klowest in 5 years 2022: €720k▲ +767% vs 2021 2023: €518k▼ -28.1% vs 2022 2024: €886k▲ +71.1% vs 2023highest in 5 years 2025: €619k▼ -30.2% vs 2024

Net result€44k-€468k▲ 955%€628k▲ 34.1%€829k▲ 31.9%€235k▼ 71.6% 2021: €44klowest in 5 years 2022: €468k▲ +955% vs 2021 2023: €628k▲ +34.1% vs 2022 2024: €829k▲ +31.9% vs 2023highest in 5 years 2025: €235k▼ -71.6% vs 2024

Result per fiscal year

Operating resultNet result

The operating result falls in 2025; 2025 is 30% below 2024.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €10.06M

99.3%

Fixed assets €68k ▼ 84.4%

Current assets €9.99M ▲ 16.2%

Equity and liabilities €10.06M

41.0%

59.0%

Equity €4.12M ▲ 6.0%

Debt €5.93M ▲ 15.4%

Debt's share of the balance-sheet total rises from 56.9% to 59.0%. Equity and debt are higher.

Key figures and ratios

2025 value · change against 2024

EBITDA

€637k▼

2024 · €900k

Cash flow

€253k▼

2024 · €843k

Current ratio

5.70▼

2024 · 6.13

Debt to equity

1.44▲

2024 · 1.32

ROE

5.7%▼

2024 · 21.3%

ROA

2.3%▼

2024 · 9.2%

Interest coverage

7.09▼

2024 · 8.67

Debt ≤ 1 year

€1.75M▲

2024 · €1.40M

Staff costs

€2.99M▲

2024 · €2.79M

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

As filed By statement

Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines

Balance sheet Code20242025

Assets

Total assets20/58€9.03M€10.06M▲

Fixed assets21/28€437k€68k▼

Intangible fixed assets21€3k€0▼

Tangible fixed assets22/27€16k€22k▲

Land and buildings22€0-

Furniture and vehicles24€16k€22k▲

Other tangible fixed assets26€0€0=

Financial fixed assets28€418k€46k▼

Current assets29/58€8.60M€9.99M▲

Amounts receivable within one year40/41€2.77M€2.79M▲

Trade receivables40€2.65M€2.78M▲

Other amounts receivable41€118k€11k▼

Current investments50/53€2.13M€3.43M▲

Cash at bank and in hand54/58€3.39M€2.73M▼

Deferred charges and accrued income490/1€297k€1.03M▲

Equity and liabilities

Total equity and liabilities10/49€9.03M€10.06M▲

Equity10/15€3.89M€4.12M▲

Contributions10/11€1.49M€1.49M=

Capital10€1.49M€1.49M=

Reserves13€1.45M€1.45M=

Profit (loss) carried forward14€950k€1.19M▲

Amounts payable17/49€5.14M€5.93M▲

Amounts payable within one year42/48€1.40M€1.75M▲

Current portion of amounts payable after more than one year42€67k-

Trade debts44€822k€1.13M▲

Suppliers440/4€822k€1.13M▲

Taxes, remuneration and social security45€512k€619k▲

Taxes450/3€25k€64k▲

Remuneration and social security454/9€487k€555k▲

Accrued charges and deferred income492/3€3.74M€4.18M▲

Income statement Code20242025

Remuneration, social security and pensions62€2.79M€2.99M▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14k€18k▲

Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€10k€13k▲

Other operating charges640/8€20k€16k▼

Non-recurring operating charges66A€15-

Gross operating margin9900€3.72M€3.65M▼

Operating profit (loss)9901€886k€619k▼

Financial income75/76B€47k€79k▲

Recurring financial income75€46k€30k▼

Non-recurring financial income76B€371€49k▲

Financial charges65/66B€104k€462k▲

Recurring financial charges65€104k€90k▼

Non-recurring financial charges66B-€373k

Profit (loss) for the period before taxes9903€829k€235k▼

Profit (loss) for the period9904€829k€235k▼

Profit (loss) for the period to be appropriated9905€829k€235k▼

Appropriation of the result

Profit (loss) to be appropriated9906€1.55M€1.19M▼

Profit (loss) brought forward from the previous period14P€721k€950k▲

To contributions691€600k-

Social balance

Average headcount (FTE)908726.427.0▲

The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement

Income statement Balance sheet Cash flow

Line	2021	2022	2023	2024	2025	Change
Non-recurring operating income76A	€42k	€3k	-	-	-	-
Remuneration, social security and pensions62	€2.11M	€2.24M	€2.59M	€2.79M	€2.99M	▲ 7.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630	€142k	€111k	€48k	€14k	€18k	▲ 30.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4	-	-	€19k	€10k	€13k	▲ 21.2%
Other operating charges640/8	€87k	€18k	€32k	€20k	€16k	▼ 18.4%
Non-recurring operating charges66A	€127k	-	-	€15	-	-
Gross operating margin9900	€2.55M	€3.09M	€3.20M	€3.72M	€3.65M	▼ 1.7%
Operating profit (loss)9901	€83k	€720k	€518k	€886k	€619k	▼ 30.2%
Financial income75/76B	€1k	€5k	€4k	€47k	€79k	▲ 68.7%
Recurring financial income75	€1k	€5k	€4k	€46k	€30k	▼ 36.1%
Non-recurring financial income76B	-	-	-	€371	€49k	▲ 13,099%
Financial charges65/66B	€46k	€257k	€-107k	€104k	€462k	▲ 345%
Recurring financial charges65	€46k	€257k	€-107k	€104k	€90k	▼ 13.5%
Non-recurring financial charges66B	-	-	-	-	€373k	-
Profit (loss) for the period before taxes9903	€38k	€468k	€628k	€829k	€235k	▼ 71.6%
Income taxes67/77	€-6k	-	-	-	-	-
Profit (loss) for the period9904	€44k	€468k	€628k	€829k	€235k	▼ 71.6%
Profit (loss) for the period to be appropriated9905	€44k	€468k	€628k	€829k	€235k	▼ 71.6%

Line	2021	2022	2023	2024	2025	Change
Assets
Total assets20/58	€5.74M	€7.10M	€7.40M	€9.03M	€10.06M	▲ 11.4%
Fixed assets21/28	€721k	€572k	€485k	€437k	€68k	▼ 84.4%
Intangible fixed assets21	€85k	€28k	€5k	€3k	€0	▼ 100%
Tangible fixed assets22/27	€56k	€40k	€20k	€16k	€22k	▲ 43.7%
Land and buildings22	-	-	€0	€0	-	-
Furniture and vehicles24	€8k	€27k	€20k	€16k	€22k	▲ 43.7%
Other tangible fixed assets26	€48k	€13k	€0	€0	€0	-
Financial fixed assets28	€580k	€503k	€461k	€418k	€46k	▼ 89.0%
Current assets29/58	€5.02M	€6.53M	€6.92M	€8.60M	€9.99M	▲ 16.2%
Amounts receivable within one year40/41	€1.58M	€2.10M	€3.08M	€2.77M	€2.79M	▲ 0.8%
Trade receivables40	€1.49M	€1.95M	€2.85M	€2.65M	€2.78M	▲ 4.9%
Other amounts receivable41	€85k	€156k	€223k	€118k	€11k	▼ 90.4%
Current investments50/53	€2.13M	€1.94M	€2.12M	€2.13M	€3.43M	▲ 61.0%
Cash at bank and in hand54/58	€845k	€2.22M	€1.39M	€3.39M	€2.73M	▼ 19.6%
Deferred charges and accrued income490/1	€466k	€256k	€327k	€297k	€1.03M	▲ 248%
Equity and liabilities
Total equity and liabilities10/49	€5.74M	€7.10M	€7.40M	€9.03M	€10.06M	▲ 11.4%
Equity10/15	€1.96M	€2.43M	€3.06M	€3.89M	€4.12M	▲ 6.0%
Contributions10/11	-	€1.49M	€1.49M	€1.49M	€1.49M	=
Capital10	-	€1.49M	€1.49M	€1.49M	€1.49M	=
Reserves13	€851k	€851k	€851k	€1.45M	€1.45M	=
Profit (loss) carried forward14	€-375k	€93k	€721k	€950k	€1.19M	▲ 24.7%
Amounts payable17/49	€3.78M	€4.67M	€4.34M	€5.14M	€5.93M	▲ 15.4%
Amounts payable after more than one year17	€268k	€168k	€67k	-	-	-
Financial debts170/4	€268k	€168k	€67k	-	-	-
Amounts payable within one year42/48	€892k	€1.55M	€1.51M	€1.40M	€1.75M	▲ 25.1%
Current portion of amounts payable after more than one year42	€99k	€100k	€100k	€67k	-	-
Trade debts44	€489k	€1.03M	€966k	€822k	€1.13M	▲ 38.0%
Suppliers440/4	€489k	€1.03M	€966k	€822k	€1.13M	▲ 38.0%
Taxes, remuneration and social security45	€280k	€400k	€448k	€512k	€619k	▲ 20.9%
Taxes450/3	€24k	-	€11k	€25k	€64k	▲ 160%
Remuneration and social security454/9	€256k	€400k	€438k	€487k	€555k	▲ 13.9%
Accrued charges and deferred income492/3	€2.62M	€2.95M	€2.76M	€3.74M	€4.18M	▲ 11.7%

Line	2021	2022	2023	2024	2025	Change
Profit (loss) for the period9904	€44k	€468k	€628k	€829k	€235k	▼ 71.6%
+ Depreciation and write-downs630	€142k	€111k	€48k	€14k	€18k	▲ 30.9%
Operating cash flow (approximation)	€186k	€580k	€676k	€843k	€253k	▼ 69.9%
Investment in fixed assets (approximation)	-	€38k	€39k	€35k	€350k	▲ 912%
Change in cash	-	€1.38M	€-831k	€2.00M	€-665k	▼ 133%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Timeline · acts, filings and financial milestones

All 36Financial 4Gazette 22Filings 10

Next filing, fiscal year 2026, expected by 31-07-2027

2026

10-08

State Gazette act Appointments: Marianne Aznar, Luca Boldrini and 15 others

Resignations: Elizabeth Forde, Anna Kirby and Kari Tanderup22 facts ▸

General meeting, 18/05/2026
Director appointment, Marianne Aznar (director)
Director appointment, Luca Boldrini (director)
Director appointment, Kerstin Borgmann (director)
Director appointment, Catharine Clark (director)
Director appointment, Matthias Guckenberger (director)
Director appointment, Coenraad Hurkmans (director)
Director appointment, Barbara Jereczek-Fossa (director)
Director appointment, Icro Meattini (director)
Director appointment, Piet Ost (director)
Director appointment, Esther Troost (director)
Director appointment, Uulke van der Heide (director)
+10 further facts in this act

29-05

NBB filing Annual accounts filed

fiscal year 2025 · full schema

2025

14-07

State Gazette act Appointments: Marianne Aznar, Luca Boldrini and 13 others

Resignation: Nuria Jornet Sala (director)17 facts ▸

General meeting, 05-05-2025
Director appointment, Marianne Aznar (director)
Director appointment, Luca Boldrini (director)
Director appointment, Kerstin Borgmann (director)
Director appointment, Catharine Clark (director)
Director appointment, Elizabeth Forde (director)
Director appointment, Matthias Guckenberger (director)
Director appointment, Barbara Jereczek (director)
Director appointment, Anna Kirby (director)
Director appointment, Icro Meattini (director)
Director appointment, Kari Tanderup (director)
Director appointment, Esther Troost (director)
+5 further facts in this act

15-05

NBB filing Annual accounts filed

fiscal year 2024 · full schema

2024

31-12

Financial Highest result since 2018net €829k ▲31.9%

Operating result €886k, net result €829k, both a record.

26-09

State Gazette act Resignations: Dirk Verellen, Ben Slotman and Jesper Erikssena

Appointments: Luca Boldrini, Barbara Jereczek and Be Audit · Permanent representative: Ghislain DOCHEN21 facts ▸

General meeting, 29-04-2024
Director resignation, Dirk Verellen (director)
Director resignation, Ben Slotman (director)
Director resignation, Jesper Erikssena (director)
Director appointment, Luca Boldrini (director)
Director appointment, Barbara Jereczek (director)
Board composition, Matthias Guckenberger (chair)
Board composition, Anna Kirby (ancienne présidente)
Board composition, Barbara Jereczek (président élu)
Board composition, Esther Troost (treasurer)
Board composition, Marianne Aznar (member)
Board composition, Kerstin Borgmann (member)
+9 further facts in this act

17-05

NBB filing Annual accounts filed

fiscal year 2023 · full schema

06-03

State Gazette act Statutes amendment

2 facts ▸

General meeting, 22-02-2024
Statutes amendment

2023

13-07

State Gazette act Appointment: Alessandro Jacques Cortese (directeur général)

3 facts ▸

General meeting, 05-04-2023
Director appointment, Alessandro Jacques Cortese (directeur général (ceo))
Director appointment, Alessandro Jacques Cortese (délégué pour la gestion quotidienne et la représentation légale)

30-06

State Gazette act Resignation: Bernardus Johannes Maria Heijmen (director)

Appointments: Marianne Camille Aznar, Icro Meattini and 3 others8 facts ▸

General meeting, 05-04-2023
Director resignation, Bernardus Johannes Maria Heijmen (director)
Director appointment, Marianne Camille Aznar (director)
Director appointment, Icro Meattini (director)
Director appointment, Catharine Helen Clark (director)
Director appointment, Uulke Age van der Heide (director)
Director appointment, Jesper Grau Eriksen (director)
General meeting, 15-05-2023

15-06

NBB filing Annual accounts filed

fiscal year 2022 · full schema

2022

31-12

Financial Equity above €2MEq €2.43M ▲23.9%

2 profitable years in a row build equity to €2.43M.

Show earlier events

04-08

State Gazette act Resignations & appointments

Board composition12 facts ▸

General meeting, 09-05-2022
Board composition, Anna Kirby (chair)
Board composition, Berend Slotman (ancien président)
Board composition, Matthias Guckenberger (président elect)
Board composition, Dirk Verellen (treasurer)
Board composition, Elizabeth Forde (member)
Board composition, Umberto Ricardi (member)
Board composition, Ben Heijmen (member)
Board composition, Nuria Jornet (member)
Board composition, Kari Tanderup (member)
Board composition, Kerstin Borgmann (member)
Board composition, Esther Troost (member)

04-06

NBB filing Annual accounts filed

fiscal year 2021 · full schema

19-04

State Gazette act Appointment: Quali Audit - Réviseurs d'Entreprises (statutory auditor)

Permanent representative: Ghislain DOCHEN · Registered-office move16 facts ▸

General meeting, 14-04-2021
Board composition, Berend Slotman (chair)
Board composition, Umberto Ricardi (ancien président)
Board composition, Anna Kirby (president elect)
Board composition, Dirk Verellen (treasurer)
Board composition, Elisabeth Forde (member)
Board composition, Matthias Guckenberger (member)
Board composition, Ben Heijmen (member)
Board composition, Núria Jornet (member)
Board composition, Kari Tanderup (member)
Board composition, Marc Vooijs (member)
Board composition, Esther Troost (member)
+4 further facts in this act

2021

31-12

Financial Back to profitnet €44k

Net result €44k after one loss-making year.

19-08

State Gazette act Appointment: Esther Gera Cornelia Troost (director)

12 facts ▸

General meeting, 14-04-2021
Director appointment, Esther Gera Cornelia Troost (director)
Board composition, Berend Slotman (chair)
Board composition, Umberto Ricardi (ancien président)
Board composition, Anna Kirby (president elect)
Board composition, Dirk Verellen (treasurer)
Board composition, Elisabeth Forde (member)
Board composition, Matthias Guckenberger (member)
Board composition, Ben Heijmen (member)
Board composition, Núria Jornet (member)
Board composition, Marc Vooijs (member)
Board composition, Esther Gera Cornelia Troost (member)

17-05

NBB filing Annual accounts filed

fiscal year 2020 · full schema

28-04

State Gazette act Resignations: Yolande Lievens, Peter Hoskin and 2 others

Appointments: Kari Tanderup, Bernardus Heijmen and 4 others21 facts ▸

General meeting, 06-04-2020
Director resignation, Yolande Lievens (director)
Director resignation, Peter Hoskin (director)
Director resignation, Håkan Nyström (director)
Director resignation, Laura Mullaney (director)
Director appointment, Kari Tanderup (director)
Director appointment, Bernardus Heijmen (director)
Director appointment, Elizabeth Forde (director)
Director appointment, Anna Kirby (president elect)
Board composition, Berend Slotman (president)
Board composition, Umberto Ricardi (ancien président)
Board composition, Anna Kirby (president elect)
+9 further facts in this act

2020

31-12

Financial Weakest financial yearnet €-420k

Net result drops to €-420k, the lowest in the series; recovery starts the following year.

19-05

NBB filing Annual accounts filed

fiscal year 2019 · full schema

06-03

State Gazette act Resignations: Claudio Fiorino, Marianne Nordsmark and Conchita Vens

Reappointment: Matthias Guckenberger (director) · Appointments: Núria Jornet Sala, Anna Kirby and 3 others20 facts ▸

General meeting, 23-04-2019
Director resignation, Claudio Fiorino (director)
Director resignation, Marianne Nordsmark (director)
Director resignation, Conchita Vens (director)
Director reappointment, Matthias Guckenberger (director)
Director appointment, Núria Jornet Sala (director)
Director appointment, Anna Kirby (director)
Director appointment, Marc Vooijs (director)
Board composition, Umberto Ricardi (president)
Board composition, Yolande Lievens (ancien président)
Board composition, Berend Slotman (president elect)
Board composition, Dirk Verellen (treasurer)
+8 further facts in this act

2019

13-05

NBB filing Annual accounts filed

fiscal year 2018 · full schema

2018

21-12

State Gazette act Resignation: Philip Poortmans (administrateur et ancien president)

Appointments: Ben Slotman (administrateur et president élu) and DGTS - Réviseurs d'entreprises (statutory auditor)15 facts ▸

General meeting, 23-04-2018
Director resignation, Philip Poortmans (administrateur et ancien president)
Director appointment, Ben Slotman (administrateur et president élu)
Board composition, Umberto Ricardi (president)
Board composition, Yolande Lievens (ancien président)
Board composition, Ben Slotman (president elect)
Board composition, Dirk Verellen (treasurer)
Board composition, Claudio Fiorino (director (executive))
Board composition, Matthias Guckenberger (director (executive))
Board composition, Peter Hoskin (director (executive))
Board composition, Laura Mullaney (director (executive))
Board composition, Marianne Nordsmark (director (executive))
+3 further facts in this act

16-07

NBB filing Annual accounts filed

fiscal year 2017 · full schema

2017

19-06

State Gazette act Statutes amendment

15-05

NBB filing Annual accounts filed

fiscal year 2016 · full schema

2015

07-08

State Gazette act Appointment: Vanderdonck - Roobrouck - Christiaens Bedrijfsrevisoren CVBE (auditor)

2 facts ▸

General meeting, 16-12-2014
Auditor appointment, Vanderdonck - Roobrouck - Christiaens Bedrijfsrevisoren CVBE (auditor)

2014

30-07

State Gazette act Resignations: Jean Bourhis (past president) and Christine Haie-Meder (bestuurder, membership officer)

Appointments: Philip Poortmans, Yolande Lievens and 3 others22 facts ▸

General meeting, 07-04-2014
Director resignation, Jean Bourhis (past president)
Director resignation, Christine Haie-Meder (bestuurder, membership officer)
Director appointment, Philip Poortmans (president)
Director appointment, Yolande Lievens (president elect)
Director appointment, Vincenzo Valentini (past president)
Director appointment, Gert Meijer (membership officer)
Director appointment, Gert Meijer (director)
Director appointment, Peter Hoskin (director)
Board composition, Philip Poortmans (chair)
Board composition, Yolande Lievens (verkozen voorzitter)
Board composition, Vincenzo Valentini (ere voorzitter)
+10 further facts in this act

14-03

State Gazette act Resignations: Dag Rune Olsen, Claus Belka and Fiona Stewart

Appointments: Philip Poortmans, Dirk Verellen and 6 others24 facts ▸

General meeting, 29-09-2013
Director resignation, Dag Rune Olsen (director)
Director resignation, Claus Belka (director)
Director resignation, Fiona Stewart (director)
Director appointment, Philip Poortmans (president elect)
Director appointment, Dirk Verellen (treasurer (penningmeester))
Director appointment, Cornelia Marijnen (director)
Director appointment, Conchita Vens (director)
Director appointment, Joanna Kazmierska (director)
Director appointment, Ludvig Muren (director)
Director appointment, Jens Overgaard (co editors in chief of radiation & oncology bestuurder zonder stemrecht)
Director appointment, Michael Baumann (co editors in chief of radiation & oncology bestuurder zonder stemrecht)
+12 further facts in this act

2013

22-08

State Gazette act Resignation: Karin Haustermans (treasurer)

Appointment: Dirk Verellen (trésorier ad interim) · Registered-office move4 facts ▸

General meeting, 21-04-2013
Director resignation, Karin Haustermans (treasurer)
Director appointment, Dirk Verellen (trésorier ad interim)
Registered-office move, Rue Martin V n°40, 1200 Bruxelles

05-03

State Gazette act Appointment: VANDER DONCKT - ROOBROUCK - CHRISTIAENS BRDRIJFSREVISOREN CVBA (statutory auditor)

Registered-office move4 facts ▸

Board meeting, 12-11-2012
Registered-office move, 1200 Woluwé-Saint-Lambert, Rue Martin V n°40
General meeting, 25-09-2011
Auditor appointment, VANDER DONCKT - ROOBROUCK - CHRISTIAENS BRDRIJFSREVISOREN CVBA

2012

29-06

State Gazette act Appointments: HOLLYWOOD Donal, BOURHIS Jean and 9 others

Resignations: GRAU Cai, RICARDI Umberto and 6 others32 facts ▸

General meeting, 25-09-2011
Director appointment, HOLLYWOOD Donal (president elect)
Director appointment, BOURHIS Jean (past president)
Director appointment, VALENTINI Vincenzo (president)
Director appointment, OVERGAARD Jens (director)
Director appointment, HAIE-MADER Christine (director)
Director appointment, COFFEY Mary (director)
Director appointment, VERELLEN Dirk (director)
Director appointment, DAG RUNE Olsen (director)
Director appointment, MARIJNEN Cornelia (director)
Director appointment, BELKA Claus (director)
Director appointment, STEWART Fiona (director)
+20 further facts in this act

25-04

State Gazette act Statutes amendment

Purpose change · Royal decree4 facts ▸

General meeting, 31-01-2012
Purpose change, de bevordering, in al zijn aspecten, van radiotherapie (ook gekend als radiotherapie-oncologie), klinische oncologie en daarmee verband houdende onderwerpen, me…
Statutes amendment
Royal decree, 29-03-2012

2011

18-02

State Gazette act Resignations: Norman Willich, Hana Stankusova and 4 others

Reappointment: Michaël Baumann (director) · Appointments: Vincenzo Valentini, Karin Haustermans and 4 others32 facts ▸

General meeting, 22-09-2009
Director resignation, Norman Willich (director)
Director resignation, Hana Stankusova (director)
Director reappointment, Michaël Baumann (director)
Director appointment, Vincenzo Valentini (director)
Director appointment, Karin Haustermans (director)
General meeting, 15-09-2010
Director resignation, Isabel Monteiro Grillo (director)
Director resignation, Brendan McClean (director)
Director resignation, Primos Strojan (director)
Director resignation, Hans Peter Rodemann (director)
Director appointment, Cornelia Marijnen (director)
+20 further facts in this act

2007

10-12

State Gazette act Appointments: Cai GRAU, Jean BOURHIS and 6 others

Resignations: Jane DOBBS, Michael BAUMANN and 3 others15 facts ▸

General meeting, 23-09-2007
Director appointment, Cai GRAU (secretary)
Director resignation, Jane DOBBS (secretary)
Director appointment, Jean BOURHIS (president elect)
Director appointment, Vincent GREGOIRE (president)
Director resignation, Michael BAUMANN (president)
Director appointment, Brendan McCLEAN (director)
Director appointment, Isabel MONTEIRO GRILLO (director)
Director appointment, Hans Peter RODEMANN (director)
Director appointment, Primoz STROJAN (director)
Director resignation, Bernard DAVIS (director)
Director resignation, Peter LUKAS (director)
+3 further facts in this act

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

22 of 22 acts read

Directors · office · real estate

Directors

42 directors, no change since 2026

Ana Rita Lopes Simões dos Reis Ferreira

Director · since 18-05-2026

Current

Barbara Jereczek-Fossa

Director · since 18-05-2026

Current

Coenraad Hurkmans

Director · since 18-05-2026

Current

Maria Del Carmen Rodríguez

Director · since 18-05-2026

Current

Maria Del Carmen Rubio Rodríguez

Director · since 18-05-2026

Current

Piotr Andrzej Wojcieszek

Director · since 18-05-2026

Current

36 other directors

Piotr Wojcieszek

Director · since 18-05-2026

Current

Catharine Clark

Director · since 05-05-2025

Current

Coenraad Wilhelm Hurkmans

Director · since 05-05-2025

Current

CORTESE Alessandro

Daily management delegate · since 05-05-2025

Current

Esther Troost

Director · since 05-05-2025

Current

Kerstin Borgmann

Director · since 05-05-2025

Current

Marianne Aznar

Director · since 05-05-2025

Current

Matthias Guckenberger

Director · since 05-05-2025

Current

Piet Ost

Director · since 05-05-2025

Current

Uulke van der Heide

Director · since 05-05-2025

Current

Barbara Jereczek

Director · since 29-04-2024

Current

Luca Boldrini

Director · since 29-04-2024

Current

Alessandro Jacques Cortese

Directeur général (ceo) · since 05-04-2023

Current

Catharine Helen Clark

Director · since 05-04-2023

Current

Icro Meattini

Director · since 05-04-2023

Current

Jesper Grau Eriksen

Director · since 05-04-2023

Current

Marianne Camille Aznar

Director · since 05-04-2023

Current

Uulke Age van der Heide

Director · since 05-04-2023

Current

Esther Gera Cornelia Troost

Director · since 14-04-2021

Current

Bernardus Heijmen

Director · since 06-04-2020

Current

Jesper Eriksen

Director of the estro school · since 23-04-2019

Current

Michael BAUMANN

Editor in chief · since 01-01-2014

Current

Marc Vooijs

Director · since 23-04-2019

Not recently confirmed

Gert Meijer

Membership officer · since 07-04-2014

Not recently confirmed

Vincenzo Valentini

Past president · since 22-09-2009

Not recently confirmed

Joanna Kazmierska

Director · since 29-09-2013

Not recently confirmed

Ludvig Muren

Director · since 29-09-2013

Not recently confirmed

MARIJNEN Cornelia

Director · since 22-09-2009

Not recently confirmed

OVERGAARD Jens

Co editors in chief of radiation & oncology bestuurder zonder stemrecht · since 25-09-2011

Not recently confirmed

BOURHIS Jean

Past president · since 23-09-2007

Not recently confirmed

COFFEY Mary

Director · since 25-09-2011

Not recently confirmed

HAIE-MADER Christine

Director · since 25-09-2011

Not recently confirmed

HOLLYWOOD Donal

President elect · since 25-09-2011

Not recently confirmed

Normann WILLICH

Director · since 08-10-2006

Not recently confirmed

Primoz STROJAN

Director · since 23-09-2007

Not recently confirmed

Vincent GREGOIRE

President · since 23-09-2007

Not recently confirmed

18-05-2026 Ana Rita Lopes Simões dos Reis Ferreira: Appointed as Director

18-05-2026 Barbara Jereczek-Fossa: Appointed as Director

18-05-2026 Coenraad Hurkmans: Appointed as Director

18-05-2026 Maria Del Carmen Rodríguez: Appointed as Director

Full history in the Timeline (136 changes) →

Location & real-estate footprint

Registered office, Brussel · 1 establishment unit since 2003

seat establishment The establishment unit on the map

Ground area

1,957 m²

Building footprint

503 m²

Volume, LiDAR

16,080 m³

Parcel 21805E0544/00A000, Brussels · tallest building 34.6 m, ±11 floors. Linked by address, not a title deed.

32 companies at this address See who is registered here

1 establishment unit

EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY

Marnixlaan 17, 1000 BrusselNACE 73100

since 20032.189.647.118

1 parcel

Brussels 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
21805E0544/00A000	Brussels	1,957 m²	1 · 503 m²	34.6 m · 11 fl.

Linked by address, not proof of ownership

Good to know

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor

Be AuditCurrent

Auditor · represented by Ghislain DOCHEN

29-04-2024 → present

Show 3 earlier auditors

DGST & PARTNERS - REVISEUR D'ENTREPRISES-BEDRIJFSREVISOREN Auditor succeeded by Quali Audit - Reviseurs d'Entreprises in 2021	23-04-2018 → 14-04-2021
Quali Audit - Reviseurs d'Entreprises Auditor · represented by Ghislain DOCHEN succeeded by Be Audit in 2024	14-04-2021 → 29-04-2024
VRC BEDRIJFSREVISOREN Auditor succeeded by DGST & PARTNERS - REVISEUR D'ENTREPRISES-BEDRIJFSREVISOREN in 2018	25-09-2011 → 23-04-2018

Articles of association

Purpose

Het doel van ESTRO, een wetenschappelijke organisatie zonder winstoogmerk, is het bevorderen van radiotherapie (ook bekend als stralingsoncologie) in al zijn aspecten, waaronder…

Full purpose

Het doel van ESTRO, een wetenschappelijke organisatie zonder winstoogmerk, is het bevorderen van radiotherapie (ook bekend als stralingsoncologie) in al zijn aspecten, waaronder onderzoek, klinische oncologie en aanverwante onderwerpen. Dit omvat medische fysica op het gebied van stralingsoncologie, bestralingstherapie en biologie. De geografische focus van ESTRO ligt in heel Europa, maar kan worden uitgebreid naar elk land of elke regio in de wereld.

according to the deed of 06-03-2024

Structure & network

Connections & network

6 connected companies

Depth

Shared directors

This company Company Director Shareholding Click a node to look further, drag to arrange, scroll to zoom.

Linked via shared directors

FONDS EUROPEEN POUR LA DEMOCRATIE

via CORTESE Alessandro · Director

former→

EUROPA DONNA BELGIUM

Shared director

→

EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI

Shared director

→

Fondation Registre du Cancer

Shared director

→

Show 2 more companies with a shared director

Kom op tegen Kanker

Shared director

→

Kom op tegen Kanker

Shared director

→

Public money · subsidies and aid

European Union, budget

2022 to 2023 · 2 entries · 205,516 EUR in total

Year	Entries	awarded
2023	1	62,916 EUR
2022	1	142,601 EUR

Projects

INTERACT-EUROPE - INNOVATIVE COLLABORATION FOR INTER-SPECIALTY CANCER TRAINING ACROSS EUROPE

EU4Health · 01-06-2022 to 30-11-2023 · 142,601 EUR

INTERACT-EUROPE 100 - INTERACT-EUROPE 100

EU4Health · 01-12-2023 to 30-11-2026 · 62,916 EUR

European research

6 projects · 481,777 EUR EU contribution

Programmes

Seventh Framework Programme

4 entries · 481,777 EUR

Horizon Europe

2 entries

Projects

Adaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE

Seventh Framework Programme · participant · 01-04-2011 to 30-09-2017 · 161,077 EUR · ARTFORCE

Early and late health risks to normal/healthy tissues from the use of existing and emerging techniques for radiation therapy

Seventh Framework Programme · participant · 01-02-2009 to 31-03-2011 · 145,800 EUR · ALLEGRO

Multidisciplinary evaluation of the cancer risk from neutrons relative to photons using stem cells and the induction of second malignant neoplasms following paediatric radiation therapy

Seventh Framework Programme · participant · 01-01-2012 to 31-12-2015 · 100,000 EUR · ANDANTE

Union of Light-Ion Centres in Europe

Seventh Framework Programme · participant · 01-09-2009 to 31-08-2014 · 74,900 EUR · ULICE

UPright radiotherapy: Learning, Innovation, Fellowship and Training

Horizon Europe · associated partner · 01-10-2024 to 30-09-2028 · UPLIFT

Show 1 more projects

Right-time Adaptive Particle Therapy Of canceR - Personalisation through anatomical plus biological adaptation

Horizon Europe · associated partner · 01-01-2026 to 31-12-2029 · RAPTORplus

Similar companies · same sector, comparable size

MABRU

BE 0446.940.267

Brussel · Eq €4.20M

Diamantclub van Antwerpen

BE 0404.697.361

Antwerpen · Eq €4.23M

HORUS LIBRA

BE 0451.115.920

Anderlecht · Eq €4.25M

GALERIE D'ARENBERG - ARTS ET ANTIQUITES

Of 4,571 companies in sector 82300 we hold annual accounts for 1,672. 320 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification

Legal formInt'l non-profit association

Founded04-01-1988

Fiscal year end31-12

Abbreviation NL ESTRO

Activities, NACEBEL 2025

82300Organisation of conventions and trade shows

Scores and ratios are computed by Checked and are not a credit decision.